OUTCOMES OF LAPAROSCOPIC SURGERY FOR MID-RECTAL CANCER AFTER LONG-COURSE NEOADJUVANT CHEMORADIOTHERAPY AT 108 MILITARY CENTRAL HOSPITAL
Main Article Content
Abstract
ABSTRACT
Objective: To evaluate the early outcomes of laparoscopic surgery for mid-rectal cancer after long-course neoadjuvant chemoradiotherapy at 108 Military Central Hospital.
Subjects and methods: This was a retrospective descriptive study conducted on 85 patients with mid-rectal cancer who underwent long-course neoadjuvant chemoradiotherapy followed by radical laparoscopic surgery at 108 Military Central Hospital from August 2018 to August 2023.
Results: The main surgical procedure was total mesorectal excision (85.9%), followed by intersphincteric resection (8.2%). Lateral pelvic lymph node dissection was performed in 9.4% of cases. Intraoperative complications occurred in 4.8% of patients. The conversion rate to open surgery was 3.5%. The mean operative time was 126.3 ± 29.4 minutes. Early postoperative complications occurred in 12.9% of cases, most commonly urinary retention (4.7%), anastomotic leakage (2.4%). No early postoperative mortality. The mean postoperative hospital stay was 10.4 ± 5.4 days.
Conclusion: Laparoscopic surgery for mid-rectal cancer after long-course neoadjuvant chemoradiotherapy is feasible and safe, with acceptable rates of conversion to open surgery, intraoperative complications, and early postoperative complications.
Article Details
Keywords
mid-rectal cancer, long-course neoadjuvant chemoradiotherapy, laparoscopic surgery, early outcomes
References
2. Hofheinz R.D., Fokas E., Benhaim L., et al (2025). Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 36(9), 1007-1024.
3. Park J.W., Kang S.B., Hao J., et al (2021). Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial. Lancet Gastroenterol Hepatol. 6(7), 569-577.
4. van der Pas M.H., Haglind E., Cuesta M.A., et al (2013). Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 14, 210-218.
5. Kang S.B., Park J.W., Jeong S.Y., et al (2010). Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled triaL. Lancet Oncol. 11, 637-45.
6. Nguyễn Quang Huy, và cộng sự (2024). SHORT-TERM OUTCOMES OF LAPAROSCOPIC LOW ANTERIOR RESECTION SURGERY IN THE TREATMENT OF RECTAL CANCER. Tạp chí Y học Việt Nam. 544(2 (tháng 11 2024)).
7. Trịnh Văn Thảo, và cộng sự (2025). VALUATION OF EARLY OUTCOMES OF LAPAROSCOPIC LOW ANTERIOR RESECTION WITH STAPLED ANASTOMOSIS FOR RECTAL CANCER AT MILITARY HOSPITAL 175. Tạp chí Y học Cộng đồng. 66.
8. Song X.J., Liu Z.L., et al (2019). A meta-analysis of laparoscopic surgery versus conventional open surgery in the treatment of colorectal cancer. Medicine (Baltimore). 98(17).
9. Martínez-Pérez A., et al (2017). Short-term clinical outcomes of laparoscopic vs open rectal excision for rectal cancer: A systematic review and meta-analysis. World J Gastroenterol. 23(44), 7906-7916.
10. Leroy J., Jamali F., Forbes L., et al (2004). Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes. Surg Endosc. 18(2), 281-9.